Testosterone Enanthate Cost in Washington (2026): Cash, Insurance & Compounded Prices

Why One Washington Price Would Be Misleading

“Testosterone enanthate” can refer to different products. A current generic label describes a 200 mg/mL, 5 mL multidose vial for intramuscular use, NDC 0143-9750-01 (DailyMed). Xyosted is a branded single-dose subcutaneous autoinjector with different strengths, packaging, and dosing (Xyosted label). A quote for one cannot be presented as the price of the other.

Cash prices change with wholesaler supply, pharmacy, quantity, and discount program. Insurance cost changes with tier, deductible, network, and authorization. A dated package-level comparison is therefore more defensible than a statewide average.

Cash-Price Snapshot, Checked August 4, 2026

The packages are not dose or route equivalents: the generic vial is labeled for intramuscular use, while Xyosted is a weekly subcutaneous autoinjector. Coupon prices can vary by pharmacy and ZIP code, and the displayed discount may not be accepted. A Washington shopper should enter a local ZIP code, then have the pharmacy confirm the exact NDC and final amount before filling.

How to Get an Apples-to-Apples Cash Quote

Ask the prescriber or pharmacy for:

• Drug name and route: intramuscular vial or subcutaneous autoinjector
• Concentration and package size
• Quantity to be dispensed
• Manufacturer and National Drug Code
• Cash price without a discount
• Cash price with the specific discount card, if accepted
• Price of syringes, drawing needles, injection needles, and sharps disposal

Then call at least two in-network pharmacies on the same day. A lower vial price may not be lower per month if the package, discard instructions, or prescribed quantity differs. The Washington access guide covers prescription and pharmacy logistics separately from cost.

Washington Apple Health Coverage in 2026

The Washington Health Care Authority says all Apple Health managed-care plans and fee-for-service use the same Apple Health Preferred Drug List, with common prior-authorization criteria, step therapy, and quantity limits. HCA publishes dated PDLs because status can change during the year.

HCA's 2026 testosterone replacement therapy criteria are effective January 1, 2026. The existence of coverage criteria means a prescription is reviewed against medical and administrative requirements; it does not guarantee that every diagnosis, product, or request will be paid automatically.

Before filling, ask the plan or pharmacy to run the exact NDC and report:

1. Preferred or nonpreferred status
2. Prior-authorization requirement and the matching HCA criteria
3. Quantity limit
4. Whether a preferred formulation must be tried first
5. Whether the pharmacy is in network
6. Member cost after deductible or other benefit rules

The testosterone enanthate Medicaid guide explains federal-versus-state coverage concepts, but the dated Washington documents control a current Apple Health question.

Commercial Insurance

Commercial formularies vary by employer and carrier. Ask about generic intramuscular testosterone enanthate and Xyosted separately. Some plans may prefer testosterone cypionate, require prior authorization, limit quantity, or apply a higher tier to the autoinjector.

If the claim rejects, request the exact rejection code and the plan's current coverage policy. That is more useful than an informal statement that “testosterone is covered.” A covered drug can still have an unmet deductible, a nonpreferred tier, or a pharmacy-network restriction.

Clinical Criteria Affect Cost

The 2026 generic testosterone enanthate label instructs clinicians to confirm hypogonadism with morning testosterone concentrations on at least two separate days before treatment. It is labeled for specific conditions associated with deficient or absent endogenous testosterone and states that safety and efficacy for age-related hypogonadism are not established.

Those facts can overlap with coverage criteria, but a drug label is not a benefit decision. The Endocrine Society guideline also bases a hypogonadism diagnosis on compatible symptoms plus consistently low testosterone and recommends repeat morning testing (PMID 29562364). A correct diagnosis, documentation, and requested product all affect whether a claim is approved. Do not use a clinical guideline as proof of a Washington copay.

Compounded Testosterone Enanthate

A compounded product is not automatically less expensive, more available, or equivalent to an approved vial. FDA explains that compounded drugs are not reviewed for safety, effectiveness, or quality before marketing (FDA compounding questions and answers). Testosterone is also a Schedule III controlled substance.

If a prescriber identifies a patient-specific need that an approved product cannot meet, compare the full compounded quote: concentration, vial volume, shipping, supplies, beyond-use date, and required membership or visit fees. Verify the pharmacy's Washington license and ask why an FDA-approved product does not meet the need. Do not assume insurance will reimburse the compound.

No standardized, independently verifiable Washington cash price for a patient-specific compounded testosterone enanthate prescription was identified in the August 4, 2026 review. A compound should therefore be compared only with a written pharmacy quote that names the concentration, volume, carrier oil, beyond-use date, shipping, and all clinical or membership charges. A telehealth bundle cannot be compared with a retail vial unless medication, laboratory, visit, and supply costs are separated.

Telehealth and Total Annual Cost

A low advertised monthly membership may exclude laboratory testing, medication, supplies, or follow-up. Before enrolling, ask for a written breakdown and whether the clinician is licensed for the patient's Washington location. Controlled-substance prescribing requirements and pharmacy policies still apply.

The total cost can include baseline and follow-up visits, testosterone, blood tests, injection supplies, and management of adverse effects. The food and supplement interaction guide can help prevent unnecessary add-on products from being mistaken for required treatment costs.